Literature DB >> 7903316

Candida albicans genotyping in studies with patients with AIDS developing resistance to fluconazole.

E Bart-Delabesse1, P Boiron, A Carlotti, B Dupont.   

Abstract

We characterized Candida albicans strains responsible for recurrent oropharyngeal candidosis (OPC) in four patients with AIDS who developed clinical and mycological resistance to fluconazole (FCZ). Karyotype and restriction fragment length polymorphism analyses were performed on the clonal populations to differentiate relapse from reinfection, and the results were assessed with those of serotype and FCZ MICs. Despite the polymorphism in chromosomal bands larger than 2.2 Mbp related to an intraclonal variation, karyotype analysis showed a single strain type attributable to each patient. On the other hand, EcoRI and HinfI restriction fragments revealed a polymorphism for one patient between the first sample and the subsequent ones, relevant to the acquisition of a new strain causing the following episodes of OPC. This result coincided with switching of the serotype and with the acquisition of a resistance to FCZ. For the other three patients, the similarity of the DNA electrophoretic patterns and the serotype of the samples suggested that recurrence can be due to the initial strain that generates FCZ resistance. Although useful for epidemiological studies, molecular typing methods seem to be inadequate to detect the acquisition of FCZ resistance.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7903316      PMCID: PMC266158          DOI: 10.1128/jcm.31.11.2933-2937.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  37 in total

1.  Application of DNA typing methods to epidemiology and taxonomy of Candida species.

Authors:  S Scherer; D A Stevens
Journal:  J Clin Microbiol       Date:  1987-04       Impact factor: 5.948

2.  Ribosomal ribonucleic acid gene restriction patterns as potential taxonomic tools.

Authors:  F Grimont; P A Grimont
Journal:  Ann Inst Pasteur Microbiol       Date:  1986 Sep-Oct

3.  Variation of electrophoretic karyotypes among clinical isolates of Candida albicans.

Authors:  W G Merz; C Connelly; P Hieter
Journal:  J Clin Microbiol       Date:  1988-05       Impact factor: 5.948

4.  Evaluation of the modified API 20C system for identification of clinically important yeasts.

Authors:  W J Buesching; K Kurek; G D Roberts
Journal:  J Clin Microbiol       Date:  1979-05       Impact factor: 5.948

5.  In vitro susceptibilities and biotypes of Candida albicans isolates from the oral cavities of patients infected with human immunodeficiency virus.

Authors:  H C Korting; M Ollert; A Georgii; M Fröschl
Journal:  J Clin Microbiol       Date:  1988-12       Impact factor: 5.948

6.  A rapid, efficient method for isolating DNA from yeast.

Authors:  C Holm; D W Meeks-Wagner; W L Fangman; D Botstein
Journal:  Gene       Date:  1986       Impact factor: 3.688

7.  Separation of yeast chromosome-sized DNAs by pulsed field gradient gel electrophoresis.

Authors:  D C Schwartz; C R Cantor
Journal:  Cell       Date:  1984-05       Impact factor: 41.582

8.  Separation of chromosomal DNA molecules from C.albicans by pulsed field gel electrophoresis.

Authors:  R G Snell; R J Wilkins
Journal:  Nucleic Acids Res       Date:  1986-06-11       Impact factor: 16.971

9.  Strain and species identification by restriction fragment length polymorphisms in the ribosomal DNA repeat of Candida species.

Authors:  B B Magee; T M D'Souza; P T Magee
Journal:  J Bacteriol       Date:  1987-04       Impact factor: 3.490

10.  Antigenic studies of Candida. I. Observation of two antigenic groups in Candida albicans.

Authors:  H F HASENCLEVER; W O MITCHELL
Journal:  J Bacteriol       Date:  1961-10       Impact factor: 3.490

View more
  35 in total

Review 1.  The ins and outs of DNA fingerprinting the infectious fungi.

Authors:  D R Soll
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

2.  Parity among the randomly amplified polymorphic DNA method, multilocus enzyme electrophoresis, and Southern blot hybridization with the moderately repetitive DNA probe Ca3 for fingerprinting Candida albicans.

Authors:  C Pujol; S Joly; S R Lockhart; S Noel; M Tibayrenc; D R Soll
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

Review 3.  Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome.

Authors:  M A Ghannoum; J H Rex; J N Galgiani
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

Review 4.  Resistance of Candida species to fluconazole.

Authors:  J H Rex; M G Rinaldi; M A Pfaller
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

5.  Comparative resistance of Candida albicans clinical isolates to fluconazole and itraconazole in vitro and in vivo in a murine model.

Authors:  A Valentin; R Le Guennec; E Rodriguez; J Reynes; M Mallie; J M Bastide
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

6.  Variation in fluconazole efficacy for Candida albicans strains sequentially isolated from oral cavities of patients with AIDS in an experimental murine candidiasis model.

Authors:  F Barchiesi; L K Najvar; M F Luther; G Scalise; M G Rinaldi; J R Graybill
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

7.  Typing Candida albicans oral isolates from human immunodeficiency virus-infected patients by multilocus enzyme electrophoresis and DNA fingerprinting.

Authors:  P Boerlin; F Boerlin-Petzold; J Goudet; C Durussel; J L Pagani; J P Chave; J Bille
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

Review 8.  Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.

Authors:  T C White; K A Marr; R A Bowden
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

9.  Emergence of resistance of Candida albicans to clotrimazole in human immunodeficiency virus-infected children: in vitro and clinical correlations.

Authors:  R Pelletier; J Peter; C Antin; C Gonzalez; L Wood; T J Walsh
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

Review 10.  Azole resistance in Candida.

Authors:  D W Denning; G G Baily; S V Hood
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-04       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.